trial

Shiatsu Adjuvant Therapy And Placebo For Schizophrenia

NCTId NCT00788970
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 150 (estimated)
Sponsored by Herzog Hospital
Primary completion 2011-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
150 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Triple
Start
2009-01
Primary completion
2011-12
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Acupressure adjuvant therapy

Sponsors

Herzog HospitalLead Sponsor

Investigators

1
Pesach Lichtenberg, M.D.Principal Investigator

Sites

1 total
Jerusalem, Israel

Facts & assertions

4 sourced
Enrollment
150
Phase
NA
Primary Completion Date
2011-12
Status
UNKNOWN
relationships
The graph out of here
drug
Acupressure adjuvant therapy
drug
lead_sponsor
Herzog Hospital
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Pesach Lichtenberg, M.D.
person